AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 291: L747-L756, 2006. First published April 28, 2006; doi:10.1152/ajplung.00401.2005
1040-0605/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
291/4/L747    most recent
00401.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunzmann, S.
Right arrow Articles by Schmidt-Weber, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunzmann, S.
Right arrow Articles by Schmidt-Weber, C.

TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes

Steffen Kunzmann,1,4 Jo Rae Wright,2 Wolfram Steinhilber,3 Boris W. Kramer,1 Kurt Blaser,4 Christian P. Speer,1 and Carsten Schmidt-Weber4

1University Children's Hospital, Würzburg, Germany; 2Department of Cell Biology, Duke University Medical Center, Durham, North Carolina; 3Altana Pharma AG, Konstanz, Germany; and 4Swiss Institute of Allergy and Asthma Research, Davos, Switzerland

Submitted 19 September 2005 ; accepted in final form 19 April 2006

Surfactant protein A (SP-A) and transforming growth factor-beta1 (TGF-beta1) have been shown to modulate the functions of different immune cells and specifically to inhibit T lymphocyte proliferation. The aim of the present study was to elucidate whether the Smad signaling pathway, which is activated by TGF-beta1, also plays a role in SP-A-mediated inhibition of CD4+ T lymphocyte activation. Recombinant human SP-A1 expressed in Chinese hamster ovary cells [rSP-A1m (mammalian)], but not recombinant Baculovirus-derived rSP-A1hyp (hydroxyproline-deficient), suppressed T lymphocyte proliferation and IL-2 mRNA expression. To test whether SP-A induced Smad signaling, a Smad3/4-specific reporter gene was transfected in primary human CD4+ T lymphocytes. Only rSP-A1m, but not rSP-A1hyp, induced Smad-specific reporter genes, Smad2 phosphorylation, and Smad7 mRNA expression. The effect of rSP-A1m was mediated through the TGF-betaRII and could be antagonized by anti-TGF-beta1 neutralizing antibodies and sTGF-betaRII. Western blot and ELISA analysis revealed that rSP-A1m, but not rSP-A1hyp, contained TGF-beta1. TGF-beta1 was responsible for the differences in inhibition of CD4+ T lymphocyte proliferation and activation of the Smad signaling pathway between rSP-A1m and rSP-A1hyp. After acidification, native SP-A, obtained from patients with alveolar proteinosis, also induced Smad signaling in human CD4+ T lymphocytes leading to an increased inhibition of T lymphocyte proliferation, thus indicating the presence of inactive, latent TGF-beta1 in native SP-A samples. Association between SP-A and latent TGF-beta1 provides a possible novel mechanism to regulate TGF-beta1-mediated inflammation and fibrosis reactions in the lung but also leads to possible misinterpretation of immune-modulator functions of SP-A. Monitoring of SP-A preparations for possible TGF-beta1 is essential.

Smad signaling; acidification; surfactant protein A; transforming growth factor-beta1



Address for reprint requests and other correspondence: S. Kunzmann, Univ. Children's Hospital, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany (e-mail: Kunzmann_s{at}kinderklinik.uni-wuerzburg.de)




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
B. Samten, J. C. Townsend, Z. Sever-Chroneos, V. Pasquinelli, P. F. Barnes, and Z. C. Chroneos
An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis
J. Leukoc. Biol., July 1, 2008; 84(1): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. M. Pastva, J. R. Wright, and K. L. Williams
Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung Disease
Proceedings of the ATS, July 1, 2007; 4(3): 252 - 257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. R. Wright
The "wisdom" of lung surfactant: balancing host defense and surface tension-reducing functions
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L847 - L850.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.